Compliance & Validation — Documented
GxP validated, 21 CFR Part 11, HIPAA, SOC 2 Type II, ISO 27001, GDPR
Medidata Solutions
Unified platform for clinical trials data management, analytics, and decentralized trial capabilities.
Medidata is the global leader in cloud solutions for clinical research, providing a unified platform used by 2,000+ pharmaceutical, biotech, medical device, and diagnostic companies. Their AI-powered platform spans EDC, CTMS, eCOA, safety, and regulatory capabilities, processing data from over 30,000 clinical trials. Medidata was acquired by Dassault Systemes in 2019 and operates as a standalone brand within the Dassault group.
- Headquarters
- New York, United States
- Founded
- 1999
- Compliance
- GxP, 21 CFR Part 11, HIPAA, SOC 2 Type II, ISO 27001, GDPR
- Deployment options
- cloud
- Website
- https://www.medidata.com
- https://www.linkedin.com/company/medidata-solutions
Categories
AI Use Cases
- Clinical Data Management
- Medical Monitoring & Safety Review
- Patient Recruitment & Enrollment
Vendor Scorecard
100% — Complete coverage. Coverage score — how completely Atlas documents Medidata Solutions across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Documented
Per study / enterprise license
Implementation & Onboarding — Documented
3–12 months
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management, IT / Digital
Solution Scope — Documented
Clinical Data Management, Patient Recruitment, Trial Protocol Optimization
Company Viability — Documented
Private, $0 raised, 2700+ employees, Founded 1999
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Clinical Trial Activity
1 registered trial where Medidata Solutions is the lead sponsor. Source: ClinicalTrials.gov, verified 2026-07-29.
Top conditions studied: Type 2 Diabetes Mellitus
Evidence & Outcomes
Acquired by Dassault Systèmes for $5.8 billion
Dassault Systèmes acquired Medidata for approximately $5.8 billion, integrating Medidata's clinical-trial data platform into Dassault's life-sciences portfolio — one of the largest acquisitions of a clinical technology company.
regulatory filing (SEC (Medidata 8-K exhibit)) · 2019-06-12 — Partner: Dassault Systèmes
Questions to Ask This Vendor
- How does Rave RTSM handle mid-study randomization changes?
- What is the typical timeline for study build and UAT?
- How do you manage data migration from legacy EDC systems?
- What AI models power Acuity and how are they validated?